The selective serotonin reuptake inhibitors (SSRIs) were a welcome innovation
in the treatment of depression. Although these drugs are no more efficacious
than their predecessors, they are safer in overdose and more acceptable in
terms of adverse effects.1 The popularity of
the SSRIs in general, and of fluoxetine (Prozac) in particular, created its
own problems. For instance, Prozac achieved a recognition normally given to
household items in which the brand name has become identified with the generic
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 33
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
For example, in a randomized trial of selective serotonin reuptake inhibitors (SSRIs) to reduce...
Care at the Close of Life EDUCATION GUIDES
Caring for Bereaved Patients
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.